Halloran is heading to DIA 2024 Annual Global Meeting

Visit us at Booth #1029

About Halloran

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, technology, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. We aim to support our clients and the patients they serve.

Meet the Halloran DIA Team

4-4
5-1
6-1
7-1
3-May-03-2024-02-32-54-5455-PM
1-May-03-2024-02-33-10-7368-PM
2-May-03-2024-02-33-19-4265-PM
9-1
8-1

Read Our Insights

HubSpot Email Content Images (2)

The Criticality of CMO Selection for Small Biopharma Companies

For pre-clinical or early-stage biopharma companies, selecting the right Contract Manufacturing Organization (CMO) is critical to ensure future success. Explore the essential criteria for CMO selection.

Read It Here ➞

HubSpot Email Content Images (3)

Advanced Therapy Medicinal Products: Recent US Approvals, Upcoming Guidance

Advanced Therapy Medicinal Products offer new and potentially curative opportunities for the treatment of diseases or injuries, but the tactical, procedural, and logistic considerations for their development are complex. New guidance documents have been released, as well as workshops and forums, but more harmonization is needed to bring these products to market.

Read It Here ➞

HubSpot Email Content Images (4)

Pulling the Thread on FDA's Master Protocol Draft Guidance

The FDA released a draft guidance in December of 2023, expanding recommendations on the design and analysis of clinical trials conducted under a master protocol. We recently hosted an internal workshop at Halloran, collecting responses and feedback from consultants to share with the FDA for consideration.

Read It Here ➞